Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

SALE OF COMMON STOCK (Details Narrative) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended
	Sep. 28, 2017	May 10, 2018	Mar. 31, 2018	Mar. 31, 2017
Gross proceeds from stock issuance			$ 532	$ 1,102
Purchase Agreement [Member]
Number of shares issued			180,000
Gross proceeds from stock issuance			$ 600
Purchase Agreement [Member] \| Subsequent Event [Member]
Number of shares issued		450,000
Gross proceeds from stock issuance		$ 1,300
Purchase Agreement [Member] \| Lincoln Park Capital Fund, LLC ("Lincoln Park") [Member]
Number of shares issued	15,000,000
Purchase Agreement and Registration Rights Agreement [Member] \| Lincoln Park Capital Fund, LLC ("Lincoln Park") [Member]
Number of shares issued	73,039
Addition number of shares issued	300,000